A decision is expected in the fourth quarter of 2025.

Kyle Richards’ daughter Sophia Umansky detailed the unexpected side effects that surfaced four months after she started ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Cigna, which comprises the Evernorth Health Services division and the Cigna Healthcare insurance business, reported a 19% ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

"Ozempic feet" is a side effect of taking GLP-1 medications for weight loss. Here's why it happens and what you can do.

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

Taking a glucagon-like peptide 1 (GLP-1) medication can be life-changing, but it comes with a learning curve. Along with ...

More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...